Piramal Pharma Ltd Screener
Mid Cap
With a marketcap of ₹ 37,326.44 Cr Stock is ranked 225
Piramal Pharma Investment Return
Short Term
-0.02 %
25.66 %
52.41 %
83.40 %
Long Term
146.98 %
50.48 %
Piramal Pharma Return Calculator
₹
Piramal Pharma Revenue and Profit and Growth
- No Strength found.
- No Weakness found.